FDA Inspection 1190291 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 3002571151

The FDA completed an inspection of American Red Cross Blood Services on Oct 27, 2022 in Raynham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 27, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Raynham, MA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.